Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Advocacy Leadership Conference: Reflections from an Accidental Rheumatology Advocate

Samantha C. Shapiro, MD  |  May 19, 2022

Hill Visits

The next day was go-time. Hill visits were a mix of virtual and in-person meetings, with in-person the clear favorite among attendees. For the most part, we met with health legislative assistants (HLAs) and not the congresspeople themselves, but that didn’t detract from the experience in the slightest. HLAs research health-related topics and advise elected officials on legislation coming down the pipeline. So, they’re often the most knowledgeable and influential people to chat with when asking for bill support.

Visiting my state representatives in their offices could only be described as awesome. We provided a brief overview of each bill, but we weren’t there to be legislation experts. We were there to bring the impacts of the bills to life with clinical stories from the frontlines.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Writing about a 1,245-patient referral list for The Rheumatologist is one thing; sharing that figure with an elected official who could support legislation to address the workforce shortage is another. Similarly, ranting about how copay accumulator programs prevent my patients from accessing medications while saving insurance companies and pharmacy benefit managers dollars is one thing; sharing these stories with someone who might actually be able to ban these programs is much better.

In many ways, I became a rheumatology advocate by accident. But I can’t stress enough how happy I am to be here. Want to become a deliberate rheumatology advocate? ACR committees and the ALC are great places to start. These were my first Hill visits, but they certainly won’t be my last.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

If you are interested in participating in future events like these, you can sign up to get the latest updates on the ACR’s Advocates for Arthritis, to which all ACR/ARP members are welcome to apply. Be the first to know when the application period opens this summer!


Samantha C. Shapiro, MD, is an academic rheumatologist and an affiliate faculty member of the Dell Medical School at the University of Texas at Austin. She received her training in internal medicine and rheumatology at Johns Hopkins University, Baltimore. She is also a member of the ACR Insurance Subcommittee.

References

  1. https://acrabstracts.org/abstract/rheumatology-care-for-the-underserved-in-central-texas/.
  2. https://www.the-rheumatologist.org/article/lessons-from-caring-for-the-underinsured-uninsured/.
  3. https://www.rheumatology.org/Practice-Quality/Administrative-Support/Insurance-Advocacy/Tools-Resources.
  4. Battafarano DF, Ditmyer M, Bolster MB, et al. 2015 American College of Rheumatology Workforce Study: Supply and Demand Projections of Adult Rheumatology Workforce, 2015–2030. Arthritis Care and Research. 2018;70(4):617-626.
  5. https://www.goodrx.com/insurance/health-insurance/copay-accumulator-programs-cms-ruling.
  6. https://www.goodrx.com/healthcare-access/patient-advocacy/what-are-manufacturer-copay-cards.

Page: 1 2 3 | Single Page
Share: 

Filed under:InsuranceLegislation & AdvocacyProfessional Topics Tagged with:ACR Capitol Hill visitACR Insurance Subcommittee (ISC)Advocacy Leadership Conferencecopay accumulatorsdrug costsworkforce shortage

Related Articles
    felipe caparros / shutterstock.com

    Copay Accumulator Programs Can Derail Rheumatologic Treatment Plans

    February 13, 2020

    As the medications for rheumatology become more expensive, the need for patient financial assistance becomes paramount. Unfortunately, commercially insured patients are finding it difficult to afford the exorbitant copays required by their plans, and the latest strategy of pharmacy benefit managers (PBMs) threatens to derail rheumatologic treatment goals. High deductible plans combined with copay accumulator…

    New Wins, Ongoing Challenges for ACR Insurance Subcommittee

    July 3, 2019

    Corrections to reimbursement system errors with Aetna and a Medicare contractor demonstrate the latest wins for all providers by the ACR’s Insurance Subcommittee. But the committee remains hard at work advocating for rheumatologists on several fronts.

    What to Expect in Healthcare Policy from the 2023 State Legislative Sessions

    February 21, 2023

    With 2023 state legislative sessions underway, early prevailing themes may forecast areas where we will see gains this year. Key issues include utilization management, copay accumulator bans, white bagging and pharmacy benefit manager reform.

    ACR Leads Resolution to Address Copay Accumulator Policies at AMA House of Delegates Meeting

    November 6, 2020

    If passed, the ACR-authored resolution will direct the AMA to advocate for copay accumulator bans at state and federal levels. Several other specialties and state medical associations have joined the resolution as cosponsors.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences